(IBC3) iShares Core MSCI EM IMI - Ratings and Ratios
Equities, Emerging Markets, Shares, Exposure
Description: IBC3 iShares Core MSCI EM IMI
The iShares Core MSCI EM IMI UCITS ETF (XETRA:IBC3) is an exchange-traded fund that tracks the Morningstar Emerging Markets TME NR USD Index, providing investors with broad exposure to emerging markets equities. As a Germany-domiciled ETF, it is designed to capture the performance of a diversified universe of large-, mid-, and small-cap stocks across various emerging markets.
From a technical analysis perspective, the ETFs price action indicates a relatively stable trend, with its 20-day simple moving average (SMA) at €4.50 and its 50-day SMA at €4.36, suggesting a potential bullish crossover. The 200-day SMA at €4.47 is closely aligned with the current price, indicating a strong support level. The average true range (ATR) of 0.05, equivalent to 1.22%, suggests moderate volatility. Given the current technical setup, we can anticipate a potential price movement towards the 52-week high of €4.75, with a possible resistance level around €4.60.
Fundamentally, the iShares Core MSCI EM IMI UCITS ETF has a substantial asset base, with approximately €19.952 billion in assets under management (AUM). This scale provides the ETF with a high degree of liquidity and diversification, making it an attractive option for investors seeking broad emerging markets exposure. As emerging markets continue to evolve, the ETFs diversified portfolio is well-positioned to capture growth opportunities across various sectors and geographies.
Combining technical and fundamental insights, our forecast suggests that the ETF is likely to experience a moderate price appreciation in the near term, driven by its strong technical setup and favorable fundamental characteristics. We anticipate the price to potentially reach €4.70 within the next few weeks, with a possible extension towards €4.80 in the event of a sustained bullish trend. However, investors should remain vigilant and monitor the ETFs price action and underlying fundamentals to adjust their strategies accordingly.
Additional Sources for IBC3 ETF
IBC3 ETF Overview
Market Cap in USD | 23,311m |
Category | Global Emerging Markets Equity |
TER | 0.18% |
IPO / Inception | 2018-03-05 |
IBC3 ETF Ratings
Growth Rating | 33.1 |
Fundamental | - |
Dividend Rating | 43.5 |
Rel. Strength | -17.9 |
Analysts | - |
Fair Price Momentum | 4.34 EUR |
Fair Price DCF | - |
IBC3 Dividends
Dividend Yield 12m | 2.49% |
Yield on Cost 5y | 3.35% |
Annual Growth 5y | 3.41% |
Payout Consistency | 95.1% |
Payout Ratio | % |
IBC3 Growth Ratios
Growth Correlation 3m | 86% |
Growth Correlation 12m | 31.9% |
Growth Correlation 5y | 38.2% |
CAGR 5y | 6.44% |
CAGR/Max DD 5y | 0.28 |
Sharpe Ratio 12m | 0.95 |
Alpha | -1.23 |
Beta | 0.614 |
Volatility | 12.85% |
Current Volume | 217.2k |
Average Volume 20d | 107.7k |
Stop Loss | 4.6 (-2.3%) |
As of July 16, 2025, the stock is trading at EUR 4.71 with a total of 217,190 shares traded.
Over the past week, the price has changed by +1.57%, over one month by +2.68%, over three months by +13.57% and over the past year by +5.68%.
Neither. Based on ValueRay´s Analyses, iShares Core MSCI EM IMI is currently (July 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 33.10 and therefor a technical neutral rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of IBC3 is around 4.34 EUR . This means that IBC3 is currently overvalued and has a potential downside of -7.86%.
iShares Core MSCI EM IMI has no consensus analysts rating.
According to our own proprietary Forecast Model, IBC3 iShares Core MSCI EM IMI will be worth about 4.9 in July 2026. The stock is currently trading at 4.71. This means that the stock has a potential upside of +3.61%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 4.9 | 3.6% |